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Introduction 
Pork and pork products are considered to be a major source of human 
salmonellosis in the United Kingdom (UK). Despite a number of control programmes 
implemented within the UK, such as the Zoonoses National Control Programme 
(ZNCP), the prevalence of Salmonella in the UK slaughter pig population remains over 
20% [1]. In particular, S. Typhimurium (including monophasic variants) continues to be 
a predominant serotype in humans, which is known to be most commonly found in pigs 
[2]. Therefore, to identify potential control measures that could reduce the number of 
human Salmonella cases it is necessary to understand the farm-to-consumption chain for 
pork and pork products. However, implementing control measures across the whole pig 
industry and food-chain would be a costly large scale project. It is therefore important to 
assess whether the benefit of implementing the control measures justifies the cost.   
Cost-benefit analysis (CBA) is a standard method employed in a number of fields 
to assess whether a change in a process will produce a beneficial result and/or in a 
situation where a number of changes are proposed, to predict which change would 
produce the biggest benefit. CBAs are increasingly being employed in the field of 
epidemiology and food safety, for example to assess which control measures should be 
implemented within the food-to-consumption pathway. In these cases two main inputs 
are needed; a mathematical model to determine the effectiveness of the control measure 
(e.g. the reduction in number of cases of Salmonella) and an estimate of the costs, and 
savings made, of implementing the intervention. One of the most commonly used 
metrics to report results of a CBA is the ‘benefit-cost ratio’ (BCR), which gives an 
indication of how much benefit is obtained for each unit of cost, with a BCR>1 
indicating that the benefits outweigh the costs. 
Previous work has identified numerous risk factors as potential drivers of 
Salmonella transmission on pig farms; such as types of flooring, feed types and 
composition, and annual number of pig deliveries [3, 4]. However, results from 
previous CBA’s were not promising in terms of the overall cost-benefit to the European 
Union (EU) for Salmonella control at the stage of the live animal, whereby 
interventions produced BCRs considerably less than 1, both for the UK and worldwide 
[5-8]. One study estimated the BCR for the UK to be greater than one under a number 
of scenarios investigated [5]. While the positive cost-benefit appears to be due to the 
relatively high prevalence of Salmonella infection in UK pigs compared to the rest of 
the EU, it is worth investigating further.  
The aim of this study was to conduct a cost-benefit analysis for Salmonella 
control measures on pig farms, utilising recent data from studies on UK pig farms  to 
estimate whether any interventions would produce a positive cost-benefit to the industry 
and if not what would be the predicted change in cost to achieve it.  
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Materials and methods 
To determine the cost-benefit of an intervention, i, a simple benefit-cost ratio, 
BCR(i) was used  
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where C(i) was the total cost of intervention i to the UK pig industry (£/year), S(i) 
the total saving (£/year) made from a reduction in human cases of Salmonella 
attributable to domestic pig meat consumption and B(i) the saving to the industry 
(£/year) from intervention i. It is clear from the equation, that if S(i) + B(i) ≥ C(i) then 
BCR(i) ≥ 1, resulting in a net gain to the UK economy. The cost to the industry (C(i) 
£/year) for intervention i was given by C(i)=cpp(i)*NT, where cpp(i) is the cost per pig 
(£) for intervention i and NT is the total number of pigs slaughtered in the UK per year, 
assumed to be 10.23 million. The total economic productivity saving as a result of 
implementing intervention i, S(i), was given by S(i)=cH*H(i), where cH is the cost (£) 
per human case of Salmonella, estimated to be £503.34, and H(i) is the annual number 
of human cases prevented by intervention i. The saving to the industry, B(i), is given by 
B(i)=b(i)*W(i), where b(i) is the savings per pig by preventing infection from 
intervention i, estimated to be £1.22, and W(i) the annual number of pig cases prevented 
by intervention i. By substituting these values into the BCR equation, rearranging and 
setting BCR(i)=1, we can obtain an equation for the cost per pig to get zero cost-benefit; 
cpp0(i)= ( cHH(i)+b(i)*W(i) ) / NT. 
Within this study, we assessed five interventions; vaccination, movement to an 
outdoor breeding unit, improved cleaning and disinfection practices, fermented liquid 
feed (wet feed) and use of organic acids in feed. Whenever there was uncertainty about 
parameterisation we erred towards a ‘best-case scenario’, so the results of the CBA are 
an upper estimate of how cost-effective we expect the interventions to be based on the 
available data. The model used here to obtain subsequent effectiveness estimates along 
the farm-to-consumption chain was a quantitative microbiological risk assessment 
(QMRA) previously developed for the European Food Safety Authority (EFSA) by a 
European consortium including APHA, RIVM and Food DTU [9, 10]. For each 
scenario tested, the QMRA is modified to simulate the effect of the intervention and 
estimates are obtained for the resulting percentage change in national pig prevalence at 
the point of leaving the farm, pw(i), and prevalence of human cases, ph(i). As such, the 
total number of prevented pig cases per intervention, is given by W(i)= W0*pw(i), where 
W0 is the number of pig cases predicted by the QMRA in the absence of the 
intervention. The number of prevented human cases per intervention is given by H(i) 
=H0*ph(i), where H0 is the total number of domestic pig meat-attributable human cases 
of Salmonella. Note that while ph(i) is estimated using the QMRA, H0 is estimated from 
data according to the equation, H0=Nh*Uf*psa*puk,, where Nh is the total number of 
reported UK human cases of Salmonella, Uf is the under-reporting factor, i.e. ratio of 
community to laboratory confirmed cases, psa is the proportion of human Salmonella 
cases attributed to pigs and puk is the proportion of UK-produced pig meat that enters 
the UK food chain, as opposed to being exported to another country. The costs were 
either provided by the companies conducting the intervention studies or estimated from 
the literature. The global parameter estimates are shown in Table1. 
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Results 
The results of the CBA analysis (Table 1) suggest that none of the on-farm 
interventions were predicted to achieve a net gain to the UK economy (i.e. BCR >1). 
The intervention with the highest BCR was the addition of organic acids to pig feed. 
Analysis of what the cost per pig would need to be in order to achieve a BCR=1, 
suggests that all interventions would need to be considerably cheaper; e.g. the cost of 
the vaccine would need to reduce from £0.60 to £0.39 per pig.  
 
Table 1. Cost-benefit results, showing QMRA results of % reduction in slaughter pig prevalence and 
reduction in human cases, estimates of the intervention cost per pig and financial savings to pig 
productivity and human illness, along with the resulting BCR and the estimated cost per pig necessary to 
achieve a BCR equal to 1. 
Intervention 
CBA Model Inputs Results 
Reduction 
in national 
slaughter 
pig 
prevalence 
(%), pw(i) 
Cost 
per 
pig, £ 
per 
year, 
cpp(i) 
Cost of 
nationwide 
implementation, 
£’000 per year, 
C(i) 
Benefit to pig 
productivity, 
£’000 per 
year, B(i) 
Reduction 
in human 
cases per 
year, H(i) 
Human 
illness 
savings, 
£’000 
per 
year, 
S(i) 
Benefit-
Cost 
Ratio, 
BCR(i) 
Cost per 
pig to 
achieve 
BCR 
=1, £ 
per year 
cpp0(i) 
Wet feed 58.8* £1.16 £9,645k £1,260k 6,086 £3,063k 0.448 £0.423 
Organic acids 94.6* £0.80 £8,184k £2,502k 9,171 £4,616k 0.870 £0.696 
Vaccination 48.8 £0.60 £6,179k £1,290k 5,321 £2,678k 0.642 £0.388 
Cleaning & 
disinfection 
28.9 £5.21 £53,298k £764k 3,244 £1,633k 0.0450 £0.2343 
Movement to 
outdoor 
breeding unit 
40.1 £0.75 £7,673k £1,059k 4,745 £2,388k 0.449 £0.337 
*These reductions are a result of the APHA QMRA farm model, rather than extrapolated from an experimental study. 
  
Discussion 
There are large uncertainties associated with how representative the experimental 
intervention studies are if implemented on a national level, not least because of the 
relatively small sample size. For example, the organic acids intervention, which 
assumes that pigs will not shed more than 10
4
 cfu/g, gives a high reduction in national 
slaughter pig prevalence, but is very much a best case estimate and would benefit from 
further UK studies that could demonstrate a product can achieve this in practice. Also, 
while there are clearly costs associated with outdoor units, it is possible that the land 
may be used for other sources of income (e.g. sugar beet or cereal crops), which would 
in turn lower the costs calculated previously. If further investigation can prove that there 
is a link between Salmonella infection and Key Performance Indicators then this will 
impact the BCR by increasing the financial benefit to the farmer by preventing cases of 
Salmonella. There are around 10,000 pig farms in the UK, although the vast majority of 
production comes from a much smaller number of large scale industrial farms. Thus, 
another possible way to improve the benefit-cost ratio of interventions would be to 
make them risk-based, e.g. to target intervention measures at a sub-set of farms, thus 
reducing the scale (and cost) of the operation required by the UK pig industry to reduce 
human risk. Such a risk-based approach could target larger farms or use Salmonella 
monitoring data to target farms with a high prevalence of infection, which could also act 
as an incentive for improvement. Consequently, the investigation of a risk-based 
intervention programme on human Salmonellosis due to the consumption of pork/pork 
products would be beneficial. 
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There are other factors not considered in this analysis that may provide additional 
benefits, such as the interventions being effective against other foodborne and pig 
diseases and the effect of combining multiple interventions. Intervention measures 
further down the farm-to-consumption chain, e.g. slaughterhouse interventions such as 
anal bunging, more thorough scalding, double singeing or improved slaughter hygiene 
to reduce cross-contamination, might incur a lower cost as there are fewer 
slaughterhouses than pig farms to implement interventions and less opportunities further 
down the chain for re-contamination or cross-contamination of carcasses to occur. 
However, such interventions would have no benefit to pig productivity so could well be 
less cost-effective. 
 
Conclusion 
Even under the best case scenarios (full implementation of effective intervention 
across the UK), the estimated cost of implementing all interventions exceeds the 
estimated financial benefit to pig productivity and human health. However, there are 
factors other than simple cost, e.g. Government targets to reduce foodborne illness, 
trade, societal pressure due to fear of contaminated meat products, which may 
encourage the desire for implementation of control measures. The analysis here would 
help in the determination of which interventions would be the most beneficial.  
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